Product Code: GVR-4-68040-436-6
Shilajit Market Growth & Trends:
The global shilajit market size is expected to reach USD 320.1 million by 2030, registering a CAGR of 9.0%, according to a new report by Grand View Research, Inc. Shilajit, a natural substance that exudes from sedimentary rocks in specific regions worldwide, is celebrated for its potent antioxidant and anti-inflammatory properties. The global market has experienced steady growth, driven by rising consumer interest in natural and traditional health remedies. Traditionally used in Ayurvedic medicine, Shilajit is gaining popularity due to its numerous health benefits, such as boosting energy, supporting cognitive function, enhancing physical performance, and promoting healthy aging.
As health-conscious consumers grow increasingly wary of synthetic products, the demand for natural and organic supplements has surged. With its natural composition and long-standing use in traditional medicine, Shilajit aligns perfectly with this trend. The global shift towards wellness and preventive healthcare is a significant driving force behind this demand. Consumers are increasingly seeking products that address specific ailments and promote overall well-being, further boosting the popularity of Shilajit.
The growing reach of e-commerce platforms has made Shilajit products more accessible to consumers around the world. This trend has been particularly noticeable during events like Amazon Prime Day, where brands have launched new Shilajit products to connect with a wider audience. Companies are developing Shilajit products incorporating additional beneficial ingredients such as gold dust, fulvic acid, and herbal extracts to boost their effectiveness and attractiveness. Manufacturers prioritize producing high-purity Shilajit with minimal processing to ensure products are free from fillers and additives. This focus on quality is essential for meeting consumer expectations and adhering to regulatory standards.
Shilajit Market Report Highlights:
- Liquid segment possesses a share of 61.15% in 2023. Resin Shilajit, available in semi-liquid form, is renowned for its high bioavailability, meaning the body readily and efficiently absorbs it. This leads to quicker and more noticeable effects, a key advantage for consumers looking for immediate benefits, such as improved energy or cognitive function
- Bone & joint health is expected to grow at a CAGR of 9.3% from 2024 to 2030. As the global population ages, bone and joint issues are growing, including osteoarthritis, rheumatoid arthritis, and osteoporosis. This demographic shift is boosting the demand for supplements that support bone and joint health, positioning Shilajit as a highly appealing option
- The sale of shilajit online is expected to witness a CAGR of 9.6% from 2024 to 2030. Online stores are available around the clock, enabling consumers to shop whenever it is convenient for them. This flexibility is especially attractive to busy professionals and others who may not have time to visit physical stores during standard business hours. In addition, online platforms often offer detailed product descriptions, customer reviews, and ratings, which assist consumers in making informed choices
- Asia Pacific held a market share of 61.02% in 2023. The region is experiencing a rising trend towards preventive health and wellness. Consumers are increasingly interested in natural products that promote overall health, strengthen immunity, and prevent diseases. Shilajit, known for its antioxidant and anti-inflammatory properties, is ideally positioned to capitalize on this trend. Countries such as Indonesia, Vietnam, and Thailand present significant untapped opportunities for the market
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Forms & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.6. Data Validation & Publishing
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Form Outlook
- 2.3. Application Outlook
- 2.4. Distribution Channel Outlook
- 2.5. Regional Outlook
- 2.6. Competitive Insights
Chapter 3. Shilajit Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.2. Industry Value Chain Analysis
- 3.2.1. Sales/Retail Channel Analysis
- 3.2.2. Profit Margin Analysis
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.2. Market Restraint Analysis
- 3.3.3. Industry Challenges
- 3.3.4. Industry Opportunities
- 3.4. Industry Analysis - Porter's
- 3.5. Market Entry Strategies
Chapter 4. Shilajit Market: Form Analysis & Estimates
- 4.1. Form Analysis & Market Share, 2023 & 2030
- 4.2. Liquid
- 4.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3. Powder
- 4.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.4. Capsules/Tablets
- 4.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 5. Shilajit Market: Application Estimates & Trend Analysis
- 5.1. Bone & Joint Health
- 5.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.2. Sexual Health
- 5.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3. Anti-aging
- 5.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.4. General Health
- 5.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.5. Others
- 5.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6. Shilajit Market: Distribution Channel Estimates & Trend Analysis
- 6.1. Offline
- 6.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.2. Online
- 6.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7. Shilajit Market: Regional Estimates & Trend Analysis
- 7.1. Regional Movement Analysis & Market Share, 2023 & 2030
- 7.2. North America
- 7.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.2.2. U.S.
- 7.2.2.1. Key country dynamics
- 7.2.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.2.3. Canada
- 7.2.3.1. Key country dynamics
- 7.2.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.2.4. Mexico
- 7.2.4.1. Key country dynamics
- 7.2.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3. Europe
- 7.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.2. UK
- 7.3.2.1. Key country dynamics
- 7.3.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.3. Germany
- 7.3.3.1. Key country dynamics
- 7.3.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.4. France
- 7.3.4.1. Key country dynamics
- 7.3.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.5. Spain
- 7.3.5.1. Key country dynamics
- 7.3.5.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.6. Italy
- 7.3.6.1. Key country dynamics
- 7.3.6.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.2. China
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.3. Japan
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.4. India
- 7.4.4.1. Key country dynamics
- 7.4.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.5. Australia & New Zealand
- 7.4.5.1. Key country dynamics
- 7.4.5.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.6. South Korea
- 7.4.6.1. Key country dynamics
- 7.4.6.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.7. Thailand
- 7.4.7.1. Key country dynamics
- 7.4.7.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.8. Malaysia
- 7.4.8.1. Key country dynamics
- 7.4.8.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5. Central & South America
- 7.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5.2. Brazil
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6. Middle East & Africa
- 7.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.2. South Africa
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8. Competitive Analysis
- 8.1. Recent developments & impact analysis by key market participants
- 8.2. Company Categorization
- 8.3. Participant's Overview
- 8.4. Financial Performance
- 8.5. Form Benchmarking
- 8.6. Company Market Share Analysis, 2023 (%)
- 8.7. Company Heat Map Analysis
- 8.8. Strategy Mapping
- 8.9. Company Profiles
- 8.9.1. Undersun Biomedtech Corp.
- 8.9.1.1. Company Overview
- 8.9.1.2. Financial Performance
- 8.9.1.3. Form Benchmarking
- 8.9.1.4. Strategic Initiatives
- 8.9.2. VISTERRA
- 8.9.2.1. Company Overview
- 8.9.2.2. Financial Performance
- 8.9.2.3. Form Benchmarking
- 8.9.2.4. Strategic Initiatives
- 8.9.3. Botanic Healthcare
- 8.9.3.1. Company Overview
- 8.9.3.2. Financial Performance
- 8.9.3.3. Form Benchmarking
- 8.9.3.4. Strategic Initiatives
- 8.9.4. Alpspure Lifesciences
- 8.9.4.1. Company Overview
- 8.9.4.2. Financial Performance
- 8.9.4.3. Form Benchmarking
- 8.9.4.4. Strategic Initiatives
- 8.9.5. HERBOIL CHEM
- 8.9.5.1. Company Overview
- 8.9.5.2. Financial Performance
- 8.9.5.3. Form Benchmarking
- 8.9.5.4. Strategic Initiatives
- 8.9.6. Shaanxi Huachen Biotech
- 8.9.6.1. Company Overview
- 8.9.6.2. Financial Performance
- 8.9.6.3. Form Benchmarking
- 8.9.6.4. Strategic Initiatives
- 8.9.7. Mufan Biology
- 8.9.7.1. Company Overview
- 8.9.7.2. Financial Performance
- 8.9.7.3. Form Benchmarking
- 8.9.7.4. Strategic Initiatives
- 8.9.8. Xi'an Changyue Biological Technology
- 8.9.8.1. Company Overview
- 8.9.8.2. Financial Performance
- 8.9.8.3. Form Benchmarking
- 8.9.8.4. Strategic Initiatives
- 8.9.9. Blisque Inc.
- 8.9.9.1. Company Overview
- 8.9.9.2. Financial Performance
- 8.9.9.3. Form Benchmarking
- 8.9.9.4. Strategic Initiatives
- 8.9.10. CYMBIOTIKA LLC
- 8.9.10.1. Company Overview
- 8.9.10.2. Financial Performance
- 8.9.10.3. Form Benchmarking
- 8.9.10.4. Strategic Initiatives